Published in J Biol Chem on November 21, 2003
Distinguishing molecular features and clinical characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C). PLoS One (2008) 2.23
Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol (2005) 1.15
Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J Virol (2005) 1.13
Interaction of decay-accelerating factor with coxsackievirus B3. J Virol (2007) 1.04
Interaction of alphaVbeta3 and alphaVbeta6 integrins with human parechovirus 1. J Virol (2010) 0.99
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Molecular determinants of disease in coxsackievirus B1 murine infection. J Med Virol (2011) 0.86
The random-model method enables ab initio 3D reconstruction of asymmetric particles and determination of particle symmetry. J Struct Biol (2010) 0.86
Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21. J Virol (2004) 0.84
Automated structure solution with autoSHARP. Methods Mol Biol (2007) 14.67
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature (2006) 9.30
Antibody multispecificity mediated by conformational diversity. Science (2003) 5.21
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet (2006) 5.19
Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med (2005) 4.06
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature (2009) 2.81
Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometry. Lab Chip (2009) 2.28
The complex of Arl2-GTP and PDE delta: from structure to function. EMBO J (2002) 2.24
A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat Struct Mol Biol (2008) 2.22
Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus. RNA (2002) 2.20
Molecular model of a type III secretion system needle: Implications for host-cell sensing. Proc Natl Acad Sci U S A (2006) 2.16
Helical structure of the needle of the type III secretion system of Shigella flexneri. J Biol Chem (2003) 2.15
Sarcoidosis: challenging diagnostic aspects of an old disease. Am J Med (2012) 2.10
Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res (2008) 2.07
Structural basis for complement factor H linked age-related macular degeneration. J Exp Med (2007) 2.02
Calicivirus translation initiation requires an interaction between VPg and eIF 4 E. EMBO Rep (2005) 1.98
The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat Immunol (2012) 1.97
His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem (2006) 1.79
Self-chaperoning of the type III secretion system needle tip proteins IpaD and BipD. J Biol Chem (2006) 1.72
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med (2004) 1.70
Three-dimensional reconstruction of the Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughout. Nat Struct Mol Biol (2009) 1.70
Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Invest Ophthalmol Vis Sci (2011) 1.70
Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc Natl Acad Sci U S A (2013) 1.63
Bioinformatic and functional analysis of RNA secondary structure elements among different genera of human and animal caliciviruses. Nucleic Acids Res (2008) 1.63
Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog (2011) 1.61
Caliciviruses differ in their functional requirements for eIF4F components. J Biol Chem (2006) 1.60
What's the point of the type III secretion system needle? Proc Natl Acad Sci U S A (2008) 1.58
Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J Gen Virol (2007) 1.54
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest (2009) 1.49
Pathogenesis of contact lens-associated microbial keratitis. Optom Vis Sci (2010) 1.48
Structure of the heterodimeric core primase. Nat Struct Mol Biol (2005) 1.44
Progress examination for assessing students' readiness for advanced pharmacy practice experiences. Am J Pharm Educ (2009) 1.43
Translocon-independent intracellular replication by Pseudomonas aeruginosa requires the ADP-ribosylation domain of ExoS. Microbes Infect (2012) 1.42
Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations. J Mol Biol (2003) 1.39
Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. Proc Natl Acad Sci U S A (2011) 1.38
Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest Ophthalmol Vis Sci (2003) 1.37
An atomic resolution model for assembly, architecture, and function of the Dr adhesins. Mol Cell (2004) 1.37
Structural insights into the transcriptional and translational roles of Ebp1. EMBO J (2007) 1.37
Twitching motility contributes to the role of pili in corneal infection caused by Pseudomonas aeruginosa. Infect Immun (2003) 1.35
Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55). J Biol Chem (2004) 1.35
Helical packing of needles from functionally altered Shigella type III secretion systems. J Mol Biol (2005) 1.31
Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model. Invest Ophthalmol Vis Sci (2003) 1.31
The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa. Clin Exp Optom (2002) 1.30
Recombinants between Deformed wing virus and Varroa destructor virus-1 may prevail in Varroa destructor-infested honeybee colonies. J Gen Virol (2010) 1.30
Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect Immun (2005) 1.29
Structural analysis of substrate binding by the TatBC component of the twin-arginine protein transport system. Proc Natl Acad Sci U S A (2009) 1.29
Bioinformatic and physical characterizations of genome-scale ordered RNA structure in mammalian RNA viruses. J Virol (2008) 1.29
Structure of and influence of a tick complement inhibitor on human complement component 5. Nat Immunol (2008) 1.29
Factors required for the Uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J Virol (2005) 1.29
Timing is everything: the regulation of type III secretion. Cell Mol Life Sci (2009) 1.27
Notch receptor-ligand binding and activation: insights from molecular studies. Semin Cell Dev Biol (2012) 1.26
Mutation of retS, encoding a putative hybrid two-component regulatory protein in Pseudomonas aeruginosa, attenuates multiple virulence mechanisms. Microbes Infect (2005) 1.26
The type III needle and the damage done. Curr Opin Struct Biol (2005) 1.25
Architecture of the major component of the type III secretion system export apparatus. Nat Struct Mol Biol (2012) 1.24
Modification of Pseudomonas aeruginosa interactions with corneal epithelial cells by human tear fluid. Infect Immun (2003) 1.23
Specific DNA recognition mediated by a type IV pilin. Proc Natl Acad Sci U S A (2013) 1.23
Structure of the TatC core of the twin-arginine protein transport system. Nature (2012) 1.23
A hepatitis C virus cis-acting replication element forms a long-range RNA-RNA interaction with upstream RNA sequences in NS5B. J Virol (2008) 1.22
Pseudomonas aeruginosa induces membrane blebs in epithelial cells, which are utilized as a niche for intracellular replication and motility. Infect Immun (2008) 1.22
Norovirus gene expression and replication. J Gen Virol (2013) 1.17
Development of an optimized RNA-based murine norovirus reverse genetics system. J Virol Methods (2010) 1.17
Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS. Infect Immun (2006) 1.17
Structure and function analysis of the poliovirus cis-acting replication element (CRE). RNA (2003) 1.17
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci U S A (2013) 1.16
Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. Cell Rep (2012) 1.16
Expression, limited proteolysis and preliminary crystallographic analysis of IpaD, a component of the Shigella flexneri type III secretion system. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 1.15
Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication. J Virol (2006) 1.15
Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol (2005) 1.15
Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect Immun (2009) 1.14
Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J Gen Virol (2005) 1.14
Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1. RNA (2005) 1.13
The poliovirus 2C cis-acting replication element-mediated uridylylation of VPg is not required for synthesis of negative-sense genomes. J Gen Virol (2003) 1.13
An aptamer that neutralizes R5 strains of human immunodeficiency virus type 1 blocks gp120-CCR5 interaction. J Virol (2005) 1.12
Crystal structure of Spa40, the specificity switch for the Shigella flexneri type III secretion system. Mol Microbiol (2008) 1.12
Structural basis for complement factor I control and its disease-associated sequence polymorphisms. Proc Natl Acad Sci U S A (2011) 1.12
The Escherichia coli cell division protein and model Tat substrate SufI (FtsP) localizes to the septal ring and has a multicopper oxidase-like structure. J Mol Biol (2008) 1.11
The characterization of weak protein-protein interactions: evidence from DEER for the trimerization of a von Willebrand Factor A domain in solution. Angew Chem Int Ed Engl (2006) 1.10
Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules. PLoS Pathog (2012) 1.10
Complement factor I in health and disease. Mol Immunol (2011) 1.10
Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients. Clin Infect Dis (2013) 1.10
The structure of OMCI, a novel lipocalin inhibitor of the complement system. J Mol Biol (2007) 1.09
Expression, purification, crystallization and preliminary crystallographic analysis of MxiH, a subunit of the Shigella flexneri type III secretion system needle. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 1.08